Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine
- 1 April 2008
- journal article
- Published by Elsevier BV in Pulmonary Pharmacology & Therapeutics
- Vol. 21 (2), 309-316
- https://doi.org/10.1016/j.pupt.2007.07.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Ginkgo biloba inhibits bleomycin-induced lung fibrosis in ratsPharmacological Research, 2006
- N-Acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposureEnvironmental Research, 2005
- Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis*Critical Care Medicine, 2004
- In vivo antioxidant treatment protects against bleomycin‐induced lung damage in ratsBritish Journal of Pharmacology, 2003
- P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteineThorax, 2002
- EFFECT OF DESFERRIOXAMINE ON SILICA-INDUCED PULMONARY REACTIONInhalation Toxicology, 2000
- New perspectives on basic mechanisms in lung disease. 2. Neutrophil traffic in the lungs: role of haemodynamics, cell adhesion, and deformability.Thorax, 1993
- Modulation of the development of bleomycin-induced fibrosis by deferoxamine*1Toxicology and Applied Pharmacology, 1988
- Assays for Superoxide DismutaseMethods of Biochemical Analysis, 1987
- Interstitial Lung Diseases of Unknown CauseNew England Journal of Medicine, 1984